CompletedPhase 2NCT00243932
Clinical Trial of High Dose CoQ10 in ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Columbia University
- Principal Investigator
- Petra Kaufmann, MDAssistant Professor, Division of Neuromuscular Disease, Columbia University Medical Center (Clinical Principal Investigator)
- Intervention
- coenzyme Q10(drug)
- Enrollment
- 185 enrolled
- Eligibility
- 21-85 years · All sexes
- Timeline
- 2005 – 2008
Study locations (19)
- University of Arkansas for Medical Sciences, Department of Neurology, Little Rock, Arkansas, United States
- California Pacific Medical Center, San Francisco, California, United States
- University of California at San Francisco, San Francisco, California, United States
- University of Colorado Health Sciences, Dept of Neurology, Denver, Colorado, United States
- Yale University School of Medicine, Department of Neurology, New Haven, Connecticut, United States
- Northwestern University, Department of Neurology,, Chicago, Illinois, United States
- University of Chicago, Department of Neurology, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Kentucky, Dept of Neurology, College of Medicine, Lexington, Kentucky, United States
- Brigham and Women's Hospital , Department of Neurology, Boston, Massachusetts, United States
- Baystate Medical Center, Division of Critical Care Research, Springfield, Massachusetts, United States
- Minneapolis Medical Research Foundation, ,, Minneapolis, Minnesota, United States
- Washington University in St. Louis School of Medicine, Department of Neurology, St Louis, Missouri, United States
- Columbia Presbyterian Medical Center, The Neurological Institute, New York, New York, United States
- State University of New York Upstate Medical, Neurology Department, Syracuse, New York, United States
- +4 more locations on ClinicalTrials.gov
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00243932 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia